title: How can we manage resistance to antiangiogenic drugs?
authors.affiliation: Department of Medical Oncology & Developmental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 E Duarte Road, Duarte, CA 91010, USA.
authors.forename: Dai Chu
authors.initials: DC
authors.lastname: Luu
authors.affiliation: Department of Medical Oncology & Developmental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 E Duarte Road, Duarte, CA 91010, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Chao
keywords: CRLX101; HIF-1α; IL-17; angiogenesis; bevacizumab; drug resistance; neuropilin-1; preclinical models; predictive biomarkers; ramucirumab; β1-integrin